Please use this identifier to cite or link to this item:
|Title:||Predicting age‐specific dosing of antipsychotics|
Pollock, Bruce G.
Bies, Robert R.
|Keywords:||Schizophrenia -- Treatment|
Aging -- Health aspects
|Publisher:||John Wiley & Sons, Inc.|
|Citation:||Uchida, H., Pollock, B. G., Bies, R. R., & Mamo, D. C. (2009). Predicting age‐specific dosing of antipsychotics. Clinical Pharmacology & Therapeutics, 86(4), 360-362.|
|Abstract:||Antipsychotic medications are the standard of care for both acute and maintenance treatment of schizophrenia, the latter requiring an indefinite treatment across a patient’s life span. However, dosing and tolerability of antipsychotics have been studied primarily in younger patients, and very limited data are available for age- and phase- specific dosing. This leaves the clinician with no guidance on dose adjustment as patients grow older—an issue of critical importance, especially in light of recent concerns about increased morbidity and mortality associated with antipsychotics.|
|Appears in Collections:||Scholarly Works - FacM&SPsy|
Files in This Item:
|114.89 kB||Adobe PDF||View/Open Request a copy|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.